SIG
MDWD icon

Sargent Investment Group’s MediWound MDWD Stock Holding History

Sargent Investment Group’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$918K Buy
62,481
+3,000
+5% +$47.6K 0.11% 128
2026
Q1 		$958K Sell
59,481
-445
-0.7% -$7.74K 0.13% 115
2025
Q4 		$1.11M Hold
59,926
– – 0.14% 110
2025
Q3 		$1.08M Buy
59,926
+6,000
+11% +$111K 0.15% 91
2025
Q2 		$993K Sell
53,926
-14,764
-21% -$278K 0.13% 100
2025
Q1 		$1.07M Sell
68,690
-52,500
-43% -$939K 0.17% 91
2024
Q4 		$2.22M Buy
121,190
+3,998
+3% +$68.9K 0.36% 58
2024
Q3 		$2.12M Sell
117,192
-1,359
-1% -$24.8K 0.38% 55
2024
Q2 		$1.84M Sell
118,551
-5,857
-5% -$96.8K 0.38% 59
2024
Q1 		$1.77M Buy
124,408
+15,214
+14% +$208K 0.39% 55
2023
Q4 		$1.11M Buy
109,194
+7,125
+7% +$64K 0.24% 77
2023
Q3 		$1.09M Sell
102,069
-1,121
-1% -$10.3K 0.26% 75
2023
Q2 		$1.1M Buy
103,190
+2,389
+2% +$25.8K 0.27% 74
2023
Q1 		$1.41M Buy
100,801
+10,475
+12% +$132K 0.37% 63
2022
Q4 		$1.22M Buy
90,326
+9,990
+12% +$101K 0.38% 67
2022
Q3 		$799K Buy
80,336
+5,372
+7% +$67.7K 0.25% 78
2022
Q2 		$966K Buy
74,964
+21,428
+40% +$284K 0.3% 70
2022
Q1 		$746K Buy
53,536
+1,286
+2% +$20.8K 0.19% 95
2021
Q4 		$863K Buy
52,250
+4,571
+10% +$95.1K 0.2% 84
2021
Q3 		$1.11M Hold
47,679
– – 0.27% 64
2021
Q2 		$1.28M Sell
47,679
-4,428
-8% -$137K 0.3% 59
2021
Q1 		$1.96M Buy
52,107
+3,886
+8% +$141K 0.52% 42
2020
Q4 		$1.25M Buy
48,221
+11,721
+32% +$304K 0.39% 56
2020
Q3 		$961K Buy
36,500
+12,086
+50% +$309K 0.35% 58
2020
Q2 		$569K Buy
24,414
+7,643
+46% +$109K 0.21% 83
2020
Q1 		$184K Buy
16,771
+5,700
+51% +$105K 0.08% 132
2019
Q4 		$240K Buy
11,071
+4,285
+63% +$88.9K 0.09% 128
2019
Q3 		$152K Buy
6,786
+2,643
+64% +$58.7K 0.07% 135
2019
Q2 		$98K Buy
4,143
+2,214
+115% +$68.3K 0.04% 140
2019
Q1 		$68K Hold
1,929
– – 0.03% 132
2018
Q4 		$55K Buy
+1,929
New +$74.9K 0.03% 124

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sargent Investment Group's MDWD Position: Q2 2026 in Review

Sargent Investment Group increased its MediWound (MDWD) stake by 5% in Q2 2026, buying an estimated $47.6K and bringing the position to 62,481 shares worth $918K. The position accounts for 0.11% of the portfolio, ranked #128.

Sargent Investment Group first reported a position in MDWD in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.22M in Q4 2024. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • Sargent Investment Group held 62,481 shares of MediWound worth $918K as of Q2 2026.
  • Sargent Investment Group bought 3,000 MediWound shares in Q2 2026, an estimated $47.6K.
  • MediWound made up 0.11% of Sargent Investment Group's portfolio in Q2 2026, its #128 holding.
  • Sargent Investment Group first reported a position in MediWound in Q4 2018 and has held it in 31 quarters since.
  • Sargent Investment Group's MediWound position peaked at $2.22M in Q4 2024.
  • 79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.